Video Lectures
State-of-the-industry video lectures by leading urology experts
Latest Videos

MIAMI, FL USA ( - The efficacy of fesoterodine was assessed in patients with refractory OAB symptoms after treatment for BPH. This was a single-center pilot study of 18 male patients > 40 years of age who had bladder outlet obstruction, treated surgically, at least one month prior.

Primary endpoint was a change in International Prostate Symptom Score (IPSS) with secondary endpoints maximum urine flow rates and PVR. Fesoterodine significantly improved IPSS compared to baseline. Adverse events were: 3 (17%) patients had constipation, 1 (6%) with vision change, and 2 (11%) with dry mouth.

sufu xPresented by Lily C. Wang, Bilal Chughtai, Asha E. Jamzadeh, Richard K. Lee, Steven A. Kaplan, and Alexis E. Te at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Winter Meeting - February 25 - March 1, 2014 - Doral Golf Resort and Spa - Miami, Florida USA


Reported for by Diane K. Newman, DNP, FAAN, BCB-PMD


Upcoming urology industry events
August 1-5, 2018 / Sheraton Philadelphia Society Hill Hotel
SUFU Research Foundation Resident Preceptorship 2018
August 3-4, 2018 / Hyatt Regency Washington on Capitol Hill
Best of ASCO 2018 - Washington, DC
August 10-11, 2018 / The Palmer House Hilton, Chicago, IL
Best of ASCO 2018 - Chicago, IL
August 28-31, 2018 / ICS 2018
International Continence Society 2018
Print publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 2 Issue 4

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor